Understanding what glutathione IV therapy involves sets the foundation for a more practical question: why intravenous delivery is preferred over other forms of supplementation
It contains four of the most researched peptides- GHK-Cu, BPC-157, TB-500, and KPV
There are 3 different subtypes of POTS, each being categorized by which factor triggers the condition: Hyperadrenergic POTS An overactive sympathetic nervous system triggers this type of POTS
The full human evidence base for BPC-157: One IV safety pilot in two adults One chart review of 16 knee-pain patients, no control One chart review of 12 interstitial cystitis patients, no control One Phase I trial registered in 2015, then cancelled with no published results A Phase II hamstring-strain trial registered, no results yet That is the entire dataset
It combines the REJURAN Tone-Up Booster low-molecular-weight hydrolyzed DNA with ascorbic acid, glutathione, and tranexamic acid with an exosome and GHKCu complex